{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:12:24Z","timestamp":1791303144802,"version":"4.1.0"},"reference-count":80,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T00:00:00Z","timestamp":1757289600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objectives:<\/jats:title>\n                    <jats:p>To provide a bibliometric overview of the global research on the therapeutic applications of the suprachoroidal space (SCS) from 2000 to 2024.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Publications were retrieved from the Web of Science Core Collection using a defined search strategy. A total of 776 articles were analyzed for trends in publication volume, countries, institutions, authorship, journals, citations, and keywords. An analysis of top 10% highly cited publications was also conducted. Co-authorship, co-occurrence, and citation burst analyses were conducted using VOSviewer, bibliometrix (R), and CiteSpace.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Global publications on SCS therapy increased steadily, with a 575% growth. The United States led in output (n = 274, 35.3%) and international collaboration. Top institutions included the University of Melbourne, Bionics Institute, and Osaka University. Fujikado Takashi was the most prolific author (34 publications), while Prausnitz Mark R R had the highest citation impact (50 per article).\n                      <jats:italic toggle=\"yes\">Investigative Ophthalmology &amp; Visual Science<\/jats:italic>\n                      was the most active journal (n = 50; 2249 citations). Keyword analysis revealed three main clusters: (1) drug delivery, (2) glaucoma treatment, and (3) retinal prosthesis. Overlay map indicated that research foci have shift from implantation to injection, minimally invasive approach, and clinical trials. Burst keywords showed suprachoroidal drug delivery (including gene therapy, ranibizumab, and triamcinolone acetonide) was a rapidly evolving and promising field for innovation, which was confirmed by analysis of high-impact publications.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>This study maps the global research landscape and emerging trends on the therapeutic applications of the SCS, underscores its translational nature, and fosters interdisciplinary collaboration in this evolving field.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003384","type":"journal-article","created":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T13:04:22Z","timestamp":1757336662000},"page":"1635-1651","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Bibliometric and visualized analysis of the therapeutic application of suprachoroidal space from 2000 to 2024"],"prefix":"10.1097","volume":"112","author":[{"given":"Kehan","family":"Jin","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China"},{"name":"Beijing Key Laboratory of Fundus Diseases Intelligent Diagnosis & Drug\/Device Development and Translation, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China"},{"name":"Beijing Key Laboratory of Fundus Diseases Intelligent Diagnosis & Drug\/Device Development and Translation, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyuan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China"},{"name":"Beijing Key Laboratory of Fundus Diseases Intelligent Diagnosis & Drug\/Device Development and Translation, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China"},{"name":"Beijing Key Laboratory of Fundus Diseases Intelligent Diagnosis & Drug\/Device Development and Translation, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-5058","authenticated-orcid":false,"given":"Youxin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China"},{"name":"Key Laboratory of Ocular Fundus Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China"},{"name":"Beijing Key Laboratory of Fundus Diseases Intelligent Diagnosis & Drug\/Device Development and Translation, Beijing 100730, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,9,8]]},"reference":[{"key":"R1-20260518","doi-asserted-by":"crossref","first-page":"53\u201360","DOI":"10.1001\/jamaophthalmol.2024.5202","article-title":"In-office suprachoroidal viscopexy for acute rhegmatogenous retinal detachment","volume":"143","author":"Muni","year":"2025","journal-title":"JAMA Ophthalmol"},{"key":"R2-20260518","doi-asserted-by":"crossref","first-page":"43\u201366","DOI":"10.1016\/j.jconrel.2024.05.013","article-title":"Hollow microneedles for ocular drug delivery","volume":"371","author":"Gade","year":"2024","journal-title":"J Control Release"},{"key":"R3-20260518","doi-asserted-by":"crossref","first-page":"1654\u201359","DOI":"10.1016\/j.drudis.2019.03.027","article-title":"Targeting drug delivery within the suprachoroidal space","volume":"24","author":"Jung","year":"2019","journal-title":"Drug Discov Today"},{"key":"R4-20260518","doi-asserted-by":"crossref","first-page":"47\u201389","DOI":"10.1146\/annurev-vision-121219-081737","article-title":"Minimally invasive glaucoma surgery: a critical appraisal of the literature","volume":"6","author":"Mathew","year":"2020","journal-title":"Annu Rev Vis Sci"},{"key":"R5-20260518","doi-asserted-by":"crossref","first-page":"58\u201366","DOI":"10.1016\/j.addr.2018.03.001","article-title":"The suprachoroidal space as a route of administration to the posterior segment of the eye","volume":"126","author":"Chiang","year":"2018","journal-title":"Adv Drug Deliv Rev"},{"key":"R6-20260518","doi-asserted-by":"crossref","first-page":"1403\u201310","DOI":"10.1007\/s40265-022-01777-1","article-title":"Suprachoroidal space triamcinolone acetonide: a review in uveitic macular edema","volume":"82","author":"Fung","year":"2022","journal-title":"Drugs"},{"key":"R7-20260518","doi-asserted-by":"crossref","first-page":"170\u201377","DOI":"10.1097\/ICU.0000000000001043","article-title":"Gene therapy for age-related macular degeneration: potential, feasibility, and pitfalls","volume":"35","author":"Berkowitz","year":"2024","journal-title":"Curr Opin Ophthalmol"},{"key":"R8-20260518","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3390\/pharmaceutics13020288","article-title":"Suprachoroidal delivery of small molecules, nanoparticles, gene and cell therapies for ocular diseases","volume":"13","author":"Wan","year":"2021","journal-title":"Pharmaceutics"},{"key":"R9-20260518","doi-asserted-by":"crossref","first-page":"172\u201398","DOI":"10.1016\/j.preteyeres.2013.04.001","article-title":"Nanomedicines for back of the eye drug delivery, gene delivery, and imaging","volume":"36","author":"Kompella","year":"2013","journal-title":"Prog Retin Eye Res"},{"key":"R10-20260518","doi-asserted-by":"crossref","first-page":"2053\u201362","DOI":"10.1016\/j.addr.2005.09.007","article-title":"Ocular delivery using poly(ortho esters)","volume":"57","author":"Heller","year":"2005","journal-title":"Adv Drug Deliv Rev"},{"key":"R11-20260518","doi-asserted-by":"crossref","first-page":"866\u201393","DOI":"10.1007\/s13346-020-00843-z","article-title":"Corticosteroids in ophthalmology: drug delivery innovations, pharmacology, clinical applications, and future perspectives","volume":"11","author":"Gaballa","year":"2021","journal-title":"Drug Deliv Transl Res"},{"key":"R12-20260518","doi-asserted-by":"crossref","first-page":"121191","DOI":"10.1016\/j.biomaterials.2021.121191","article-title":"Implantation and long-term assessment of the stability and biocompatibility of a novel 98 channel suprachoroidal visual prosthesis in sheep","volume":"279","author":"Eggenberger","year":"2021","journal-title":"Biomaterials"},{"key":"R13-20260518","doi-asserted-by":"crossref","first-page":"296\u2013309","DOI":"10.4103\/1008-682X.171582","article-title":"Bibliometrics: tracking research impact by selecting the appropriate metrics","volume":"18","author":"Agarwal","year":"2016","journal-title":"Asian J Androl"},{"key":"R14-20260518","first-page":"100082","article-title":"Transparency In The reporting of Artificial INtelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R15-20260518","doi-asserted-by":"crossref","first-page":"4433\u201341","DOI":"10.1167\/iovs.12-9872","article-title":"Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye","volume":"53","author":"Patel","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R16-20260518","doi-asserted-by":"crossref","first-page":"166\u201376","DOI":"10.1007\/s11095-010-0271-y","article-title":"Suprachoroidal drug delivery to the back of the eye using hollow microneedles","volume":"28","author":"Patel","year":"2011","journal-title":"Pharm Res"},{"key":"R17-20260518","doi-asserted-by":"crossref","first-page":"777\u201387","DOI":"10.1016\/j.ajo.2006.05.045","article-title":"Cannulation of the suprachoroidal space: a novel drug delivery methodology to the posterior segment","volume":"142","author":"Olsen","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"R18-20260518","doi-asserted-by":"crossref","first-page":"2483\u201392","DOI":"10.1167\/iovs.13-11747","article-title":"Treatment of acute posterior uveitis in a porcine model by injection of triamcinolone acetonide into the suprachoroidal space using microneedles","volume":"54","author":"Gilger","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-20260518","doi-asserted-by":"crossref","first-page":"948\u201355","DOI":"10.1016\/j.ophtha.2020.01.006","article-title":"Efficacy and safety of suprachoroidal CLS-TA for macular edema secondary to noninfectious uveitis: phase 3 randomized trial","volume":"127","author":"Yeh","year":"2020","journal-title":"Ophthalmology"},{"key":"R20-20260518","doi-asserted-by":"crossref","first-page":"4749\u201356","DOI":"10.1167\/iovs.10-6291","article-title":"Pharmacokinetics of pars plana intravitreal injections versus microcannula suprachoroidal injections of bevacizumab in a porcine model","volume":"52","author":"Olsen","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R21-20260518","first-page":"1533\u201339","article-title":"Evaluation of a novel biomaterial in the suprachoroidal space of the rabbit eye","volume":"43","author":"Einmahl","year":"2002","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R22-20260518","doi-asserted-by":"crossref","first-page":"109\u201317","DOI":"10.1016\/j.jconrel.2015.02.021","article-title":"Safety and pharmacodynamics of suprachoroidal injection of triamcinolone acetonide as a controlled ocular drug release model","volume":"203","author":"Chen","year":"2015","journal-title":"J Control Release"},{"key":"R23-20260518","doi-asserted-by":"crossref","first-page":"4726\u201333","DOI":"10.1167\/iovs.10-6836","article-title":"Testing of semichronically implanted retinal prosthesis by suprachoroidal-transretinal stimulation in patients with retinitis pigmentosa","volume":"52","author":"Fujikado","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R24-20260518","doi-asserted-by":"crossref","first-page":"e115239","DOI":"10.1371\/journal.pone.0115239","article-title":"First-in-human trial of a novel suprachoroidal retinal prosthesis","volume":"9","author":"Ayton","year":"2014","journal-title":"PLoS One"},{"key":"R25-20260518","doi-asserted-by":"crossref","first-page":"560\u201366","DOI":"10.1167\/iovs.02-1268","article-title":"Electrophysiological studies of the feasibility of suprachoroidal-transretinal stimulation for artificial vision in normal and RCS rats","volume":"45","author":"Kanda","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R26-20260518","doi-asserted-by":"crossref","first-page":"385\u201388","DOI":"10.1136\/bjo.36.7.385","article-title":"Suprachoroidal air injection for detached retina; preliminary report","volume":"36","author":"Smith","year":"1952","journal-title":"Br J Ophthalmol"},{"key":"R27-20260518","doi-asserted-by":"crossref","first-page":"242\u201348","DOI":"10.2460\/ajvr.1985.46.01.242","article-title":"Aqueous outflow in the beagle: unconventional outflow, using different-sized microspheres","volume":"46","author":"Samuelson","year":"1985","journal-title":"Am J Vet Res"},{"key":"R28-20260518","doi-asserted-by":"crossref","first-page":"521\u201327","DOI":"10.1034\/j.1600-0420.1998.760502.x","article-title":"Light microscopy of uveoscleral drainage routes after gelatine injections into the suprachoroidal space","volume":"76","author":"Krohn","year":"1998","journal-title":"Acta Ophthalmol Scand"},{"key":"R29-20260518","doi-asserted-by":"crossref","first-page":"641\u201347","DOI":"10.1016\/0002-9394(75)90804-1","article-title":"Effect of immunization with attenuated mycobacterium bovis on experimental toxoplasmic retinochoroiditis","volume":"79","author":"Tabbara","year":"1975","journal-title":"Am J Ophthalmol"},{"key":"R30-20260518","doi-asserted-by":"crossref","first-page":"86\u201391","DOI":"10.1076\/ceyr.24.2.86.8159","article-title":"The effect of prinomastat (AG3340), a synthetic inhibitor of matrix metalloproteinases, on uveal melanoma rabbit model","volume":"24","author":"Ozerdem","year":"2002","journal-title":"Curr Eye Res"},{"key":"R31-20260518","doi-asserted-by":"crossref","first-page":"183\u201395","DOI":"10.3109\/02713689408995776","article-title":"Basic fibroblast growth factor experimentally induced choroidal angiogenesis in the minipig","volume":"13","author":"Soubrane","year":"1994","journal-title":"Curr Eye Res"},{"key":"R32-20260518","first-page":"281\u201389","article-title":"Suprachoroidal implantation of the inferior oblique muscle for retinal degeneration","volume":"14","author":"Tamesis","year":"1959","journal-title":"Philipp J Surg Surg Spec"},{"key":"R33-20260518","doi-asserted-by":"crossref","first-page":"1408\u201312","DOI":"10.1016\/S0161-6420(86)33553-X","article-title":"Suprachoroidal implantation for the treatment of retinal detachment","volume":"93","author":"Poole","year":"1986","journal-title":"Ophthalmology"},{"key":"R34-20260518","doi-asserted-by":"crossref","first-page":"129\u201339","DOI":"10.1007\/BF00130696","article-title":"Clinical studies on the efficiency of high power laser radiation upon some structures of the anterior segment of the eye. First experiences of the treatment of some pathological conditions of the anterior segment of the human eye by means of a Q-switched laser system","volume":"3","author":"Fankhauser","year":"1981","journal-title":"Int Ophthalmol"},{"key":"R35-20260518","first-page":"141\u201344","article-title":"Mode of action of cyclodialysis implants in man","volume":"6","author":"Gills","year":"1967","journal-title":"Invest Ophthalmol"},{"key":"R36-20260518","doi-asserted-by":"crossref","first-page":"354\u201359","DOI":"10.1097\/00061198-200308000-00010","article-title":"Suprachoroidal seton implantation in refractory glaucoma: a novel surgical technique","volume":"12","author":"Ozdamar","year":"2003","journal-title":"J Glaucoma"},{"key":"R37-20260518","doi-asserted-by":"crossref","first-page":"107824","DOI":"10.1016\/j.exer.2019.107824","article-title":"Collagenase injection into the suprachoroidal space of the eye to expand drug delivery coverage and increase posterior drug targeting","volume":"189","author":"Jung","year":"2019","journal-title":"Exp Eye Res"},{"key":"R38-20260518","doi-asserted-by":"crossref","first-page":"555\u201364","DOI":"10.1167\/iovs.16-20377","article-title":"Thickness and closure kinetics of the suprachoroidal space following microneedle injection of liquid formulations","volume":"58","author":"Chiang","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R39-20260518","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3390\/pharmaceutics13070967","article-title":"Drug delivery via the suprachoroidal space for the treatment of retinal diseases","volume":"13","author":"Naftali Ben Haim","year":"2021","journal-title":"Pharmaceutics"},{"key":"R40-20260518","doi-asserted-by":"crossref","first-page":"46913\u201323","DOI":"10.18632\/oncotarget.10442","article-title":"Cell surgery and growth factors in dry age-related macular degeneration: visual prognosis and morphological study","volume":"7","author":"Limoli","year":"2016","journal-title":"Oncotarget"},{"key":"R41-20260518","doi-asserted-by":"crossref","DOI":"10.3791\/56469","article-title":"Regenerative therapy by suprachoroidal cell autograft in dry age-related macular degeneration: preliminary in vivo report","author":"Limoli","year":"2018","journal-title":"J Vis Exp"},{"key":"R42-20260518","first-page":"223\u201337","article-title":"Mesenchymal stem cell surgery, rescue and regeneration in retinitis pigmentosa: clinical and rehabilitative prognostic aspects","volume":"38","author":"Limoli","year":"2020","journal-title":"Restor Neurol Neurosci"},{"key":"R43-20260518","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13287-021-02351-4","article-title":"Mesenchymal stem and non-stem cell surgery, rescue, and regeneration in glaucomatous optic neuropathy","volume":"12","author":"Limoli","year":"2021","journal-title":"Stem Cell Res Ther"},{"key":"R46-20260518","doi-asserted-by":"crossref","first-page":"60\u201370","DOI":"10.1016\/j.oret.2020.08.007","article-title":"Suprachoroidal CLS-TA plus intravitreal aflibercept for diabetic macular edema: a randomized, double-masked, parallel-design, controlled study","volume":"5","author":"Barakat","year":"2021","journal-title":"Ophthalmol Retina"},{"key":"R47-20260518","doi-asserted-by":"crossref","first-page":"692\u201397","DOI":"10.3928\/23258160-20180831-07","article-title":"Suprachoroidal space alterations following delivery of triamcinolone acetonide: post-hoc analysis of the Phase 1\/2 HULK study of patients with diabetic macular edema","volume":"49","author":"Lampen","year":"2018","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"R48-20260518","doi-asserted-by":"crossref","first-page":"320\u201328","DOI":"10.1016\/j.oret.2017.07.013","article-title":"Suprachoroidal triamcinolone acetonide for retinal vein occlusion: results of the tanzanite study","volume":"2","author":"Campochiaro","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R51-20260518","doi-asserted-by":"crossref","first-page":"1556\u201363","DOI":"10.1080\/09273948.2023.2262015","article-title":"Safety and efficacy of CLS-TA by anatomic location of inflammation: results from the Phase 3 PEACHTREE clinical trial","volume":"32","author":"Shah","year":"2024","journal-title":"Ocul Immunol Inflamm"},{"key":"R52-20260518","first-page":"1139\u201344","article-title":"Extension study of the safety and efficacy of CLS-TA for treatment of macular oedema associated with non-infectious uveitis (MAGNOLIA)","volume":"106","author":"Khurana","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R53-20260518","doi-asserted-by":"crossref","first-page":"802\u201306","DOI":"10.1136\/bjophthalmol-2020-318019","article-title":"Suprachoroidal CLS-TA for non-infectious uveitis: an open-label, safety trial (AZALEA)","volume":"106","author":"Henry","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R54-20260518","doi-asserted-by":"crossref","first-page":"740\u201347","DOI":"10.1038\/s41434-021-00233-1","article-title":"Proteosomal degradation impairs transcytosis of AAV vectors from suprachoroidal space to retina","volume":"28","author":"Ding","year":"2021","journal-title":"Gene Ther"},{"key":"R55-20260518","doi-asserted-by":"crossref","first-page":"682\u201393","DOI":"10.1089\/hum.2020.281","article-title":"Host immune responses after suprachoroidal delivery of AAV8 in nonhuman primate eyes","volume":"32","author":"Chung","year":"2021","journal-title":"Hum Gene Ther"},{"key":"R56-20260518","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1167\/tvst.9.13.21","article-title":"Suprachoroidally delivered DNA nanoparticles transfect retina and retinal pigment epithelium\/choroid in rabbits","volume":"9","author":"Kansara","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"R57-20260518","doi-asserted-by":"crossref","first-page":"179\u201391","DOI":"10.1016\/j.omtm.2020.01.002","article-title":"Suprachoroidal and subretinal injections of AAV using transscleral microneedles for retinal gene delivery in nonhuman primates","volume":"16","author":"Yiu","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"R58-20260518","doi-asserted-by":"crossref","first-page":"1559\u201370","DOI":"10.1038\/mt.2011.304","article-title":"Suprachoroidal electrotransfer: a nonviral gene delivery method to transfect the choroid and the retina without detaching the retina","volume":"20","author":"Touchard","year":"2012","journal-title":"Mol Ther"},{"key":"R59-20260518","doi-asserted-by":"crossref","first-page":"e17140","DOI":"10.1371\/journal.pone.0017140","article-title":"Ab-externo AAV-mediated gene delivery to the suprachoroidal space using a 250 micron flexible microcatheter","volume":"6","author":"Peden","year":"2011","journal-title":"PLoS One"},{"key":"R60-20260518","doi-asserted-by":"crossref","first-page":"777\u201388","DOI":"10.1080\/17425247.2021.1867532","article-title":"Biomechanics of suprachoroidal drug delivery: from benchtop to clinical investigation in ocular therapies","volume":"18","author":"Hancock","year":"2021","journal-title":"Expert Opin Drug Deliv"},{"key":"R61-20260518","doi-asserted-by":"crossref","first-page":"286\u201394","DOI":"10.1016\/j.actbio.2016.08.011","article-title":"Microneedle-based minimally-invasive measurement of puncture resistance and fracture toughness of sclera","volume":"44","author":"Park","year":"2016","journal-title":"Acta Biomater"},{"key":"R62-20260518","doi-asserted-by":"crossref","first-page":"967\u201383","DOI":"10.1016\/j.survophthal.2024.07.002","article-title":"Advances in ophthalmic therapeutic delivery: a comprehensive overview of present and future directions","volume":"69","author":"Torkashvand","year":"2024","journal-title":"Surv Ophthalmol"},{"key":"R63-20260518","doi-asserted-by":"crossref","first-page":"621\u201331","DOI":"10.1038\/s41551-019-0350-2","article-title":"A resistance-sensing mechanical injector for the precise delivery of liquids to target tissue","volume":"3","author":"Chitnis","year":"2019","journal-title":"Nat Biomed Eng"},{"key":"R64-20260518","doi-asserted-by":"crossref","first-page":"118\u201326","DOI":"10.1016\/j.ajo.2017.01.003","article-title":"Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt study","volume":"176","author":"Christakis","year":"2017","journal-title":"Am J Ophthalmol"},{"key":"R65-20260518","doi-asserted-by":"crossref","first-page":"155\u201361","DOI":"10.1097\/ICU.0000000000000458","article-title":"Suprachoroidal shunts","volume":"29","author":"Vinod","year":"2018","journal-title":"Curr Opin Ophthalmol"},{"key":"R66-20260518","doi-asserted-by":"crossref","first-page":"1537\u201341","DOI":"10.1136\/bjophthalmol-2011-300308","article-title":"Supraciliary shunt in refractory glaucoma","volume":"95","author":"Figus","year":"2011","journal-title":"Br J Ophthalmol"},{"key":"R67-20260518","doi-asserted-by":"crossref","first-page":"143\u201349","DOI":"10.1007\/s00417-011-1778-6","article-title":"Histological findings of failed gold micro shunts in primary open-angle glaucoma","volume":"250","author":"Agnifili","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R68-20260518","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2415-13-35","article-title":"Retrospective analysis of the success and safety of gold micro shunt implantation in glaucoma","volume":"13","author":"Hueber","year":"2013","journal-title":"BMC Ophthalmol"},{"key":"R69-20260518","doi-asserted-by":"crossref","first-page":"2699\u2013706","DOI":"10.1007\/s00417-019-04461-5","article-title":"The STARflo\u2122 glaucoma implant: a single-centre experience at 24 months","volume":"257","author":"Fili","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R70-20260518","doi-asserted-by":"crossref","first-page":"431\u201337","DOI":"10.1016\/j.jcrs.2012.10.040","article-title":"Early postoperative safety and surgical outcomes after implantation of a suprachoroidal micro-stent for the treatment of open-angle glaucoma concomitant with cataract surgery","volume":"39","author":"Hoeh","year":"2013","journal-title":"J Cataract Refract Surg"},{"key":"R71-20260518","doi-asserted-by":"crossref","first-page":"211\u201318","DOI":"10.1016\/j.ajo.2019.07.016","article-title":"Corneal endothelial cell loss and morphometric changes 5 years after phacoemulsification with or without CyPass Micro-Stent","volume":"208","author":"Lass","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R72-20260518","doi-asserted-by":"crossref","first-page":"219\u201325","DOI":"10.1016\/j.ajo.2019.07.015","article-title":"Safety and effectiveness of CyPass Supraciliary Micro-Stent in primary open-angle glaucoma: 5-year results from the COMPASS XT study","volume":"208","author":"Reiss","year":"2019","journal-title":"Am J Ophthalmol"},{"key":"R73-20260518","doi-asserted-by":"crossref","first-page":"395\u2013407","DOI":"10.1007\/s12325-018-0666-4","article-title":"Prospective evaluation of two iStent(\u00ae) trabecular stents, one iStent Supra(\u00ae) suprachoroidal stent, and postoperative prostaglandin in refractory glaucoma: 4-year outcomes","volume":"35","author":"Myers","year":"2018","journal-title":"Adv Ther"},{"key":"R74-20260518","doi-asserted-by":"crossref","first-page":"65\u201370","DOI":"10.1136\/bjophthalmol-2020-316888","article-title":"Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial","volume":"106","author":"Denis","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"R75-20260518","doi-asserted-by":"crossref","first-page":"290\u201397","DOI":"10.1016\/j.ogla.2019.06.001","article-title":"A first-in-human study of the efficacy and safety of MINIject in patients with medically uncontrolled open-angle glaucoma (STAR-I)","volume":"2","author":"Denis","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"R76-20260518","doi-asserted-by":"crossref","first-page":"217\u201322","DOI":"10.1136\/bjo-2022-322536","article-title":"Biotissue stent for supraciliary outflow in open-angle glaucoma patients: surgical procedure and first clinical results of an aqueous drainage biostent","volume":"108","author":"Ianchulev","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"R77-20260518","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1167\/tvst.10.10.7","article-title":"Functional vision in the real-world environment with a second-generation (44-channel) suprachoroidal retinal prosthesis","volume":"10","author":"Karapanos","year":"2021","journal-title":"Transl Vis Sci Technol"},{"key":"R78-20260518","doi-asserted-by":"crossref","first-page":"5782","DOI":"10.3390\/s23135782","article-title":"Retinal prostheses: engineering and clinical perspectives for vision restoration","volume":"23","author":"Wu","year":"2023","journal-title":"Sensors (Basel)"},{"key":"R79-20260518","doi-asserted-by":"crossref","first-page":"6147\u201357","DOI":"10.1167\/iovs.16-20367","article-title":"One-year outcome of 49-channel suprachoroidal-transretinal stimulation prosthesis in patients with advanced retinitis pigmentosa","volume":"57","author":"Fujikado","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R80-20260518","doi-asserted-by":"crossref","first-page":"90\u201391","DOI":"10.1016\/j.mehy.2017.08.020","article-title":"Suprachoroidal injection of biological agents may have a potential role in the prevention of progression and complications in high myopia","volume":"107","author":"Venkatesh","year":"2017","journal-title":"Med Hypotheses"},{"key":"R81-20260518","doi-asserted-by":"crossref","first-page":"629\u201337","DOI":"10.1006\/exer.2000.0825","article-title":"Choroidal vascular permeability in visually regulated eye growth","volume":"70","author":"Pendrak","year":"2000","journal-title":"Exp Eye Res"},{"key":"R82-20260518","doi-asserted-by":"crossref","first-page":"2957\u201366","DOI":"10.1167\/iovs.06-1051","article-title":"Choroidal regulation of scleral glycosaminoglycan synthesis during recovery from induced myopia","volume":"48","author":"Rada","year":"2007","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R83-20260518","doi-asserted-by":"crossref","first-page":"899\u2013905","DOI":"10.1097\/j.jcrs.0000000000001470","article-title":"Long-term astigmatism after intraocular pressure sensor implantation and nonpenetrating glaucoma surgery: EYEMATE-SC trial","volume":"50","author":"Englisch","year":"2024","journal-title":"J Cataract Refract Surg"},{"key":"R84-20260518","doi-asserted-by":"crossref","first-page":"e2302940","DOI":"10.1002\/advs.202302940","article-title":"Human pluripotent stem cells derived endothelial cells repair choroidal ischemia","volume":"11","author":"Li","year":"2024","journal-title":"Adv Sci (Weinh)"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T13:15:24Z","timestamp":1779110124000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,8]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003384","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,8]]},"assertion":[{"value":"2025-06-03","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}